Cargando…
Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models
The clinical efficacy of anti-angiogenic therapies has been difficult to predict, and biomarkers that can predict responsiveness are sorely needed in this era of personalized medicine. CVX-060 is an angiopoietin-2 (Ang2) targeting therapeutic, consisting of two peptides that bind Ang2 with high affi...
Autores principales: | Triana-Baltzer, Gallen, Pavlicek, Adam, Goulart, Ariadne, Huang, Hanhua, Pirie-Shepherd, Steven, Levin, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828186/ https://www.ncbi.nlm.nih.gov/pubmed/24244628 http://dx.doi.org/10.1371/journal.pone.0080132 |
Ejemplares similares
-
Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1
por: Tian, S, et al.
Publicado: (2002) -
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target
por: Melegari, Gabriele, et al.
Publicado: (2022) -
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
por: Kiss, Elina A., et al.
Publicado: (2019) -
Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
por: de Jong, Gerdie M., et al.
Publicado: (2016) -
The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()
por: Wang, Xiaoen, et al.
Publicado: (2014)